Vadadustat in Patients with Anemia and Non–Dialysis-Dependent CKD

Gardado en:

Detalles Bibliográficos
Publicado en:	The New England Journal of Medicine vol. 384, no. 17 (Apr 29, 2021), p. 1589
Autor Principal:	Pergola, Pablo E
Outros autores:	Farag Youssef MK, Agarwal Rajiv, Arnold, Susan, Bako Gabriel, Block, Geoffrey A, Burke, Steven, Castillo, Fausto P, Jardine, Alan G, Khawaja Zeeshan, Koury, Mark J, Lewis, Eldrin F, Lin, Tim, Luo Wenli, Maroni, Bradley J, Matsushita Kunihiro, McCullough, Peter A, Parfrey, Patrick S, Roy-Chaudhury, Prabir, Sarnak, Mark J, Sharma, Amit, Spinowitz Bruce, Tseng, Carol, Tumlin, James, Vargo, Dennis L, Walters, Kimberly A, Winkelmayer, Wolfgang C, Wittes Janet, Eckardt Kai-Uwe
Publicado:	Massachusetts Medical Society
Materias:	Akebia Therapeutics Inc United States > US Hemodialysis Clinical trials Hypoxia-inducible factors Hemoglobin Cerebral infarction Collaboration Kidney diseases Heart failure Hypoxia Myocardial infarction Confidence intervals Erythropoietin Thromboembolism Drug dosages Erythropoiesis Patients Hydroxylase Anemia Heart attacks Prolyl hydroxylase Design Safety Congestive heart failure Dialysis
Acceso en liña:	Citation/Abstract Full Text Full Text - PDF
Etiquetas:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Sexa o primeiro en deixar un comentario!